22 October 2025 · 1 min read

Round Table Announcement: The Good, the Bad, the Ugly: Pharma R&D - AI in Practice

I'm hosting a round table on November 27 in Schlieren, Zurich, bringing together pharma and Big Tech leaders to discuss what actually works — and what still fails — when applying AI in R&D. Expect candid, unscripted lessons on moving from pilot to platform, data governance, and where GenAI is genuinely helping in discovery, trial design, and safety.

Author

Christian Hein

Last updated

6 May 2026

Artificial Intelligence Generative AI Machine Learning Large Pharma Innovation Management Switzerland

Pharma leaders keep asking the same question: what actually works in R&D with AI, and what still fails in the real world?

On November 27 at 5:00 pm at our Zühlke Group HQ in Schlieren, Zurich, join an unscripted conversation focused on execution, with leading experts from big pharma (JNJ, Roche) and Big Tech (AWS). Expect candid lessons on:

Moving from pilot to platform; workflow ownership and measurable outcomes
Data quality, governance, and MLOps that survive audits
Where GenAI is already helping in discovery, trial design, and safety, and where it is not

Speakers

Scott Oloff, Vice President, R&D Data Science - Discovery, Product Development & Clinical Supply JNJ (previously SVP Data & Analytics, Roche)
Tasio Guevara, Sr. Solutions Architect Industries, Healthcare & Life Sciences, AWS
Gabriel Krummenacher, Director Data Science, Zühlke
Daniel Wilhelm, Managing Director Health Industry EMEA & Partner, Zühlke

If you lead R&D, data science, clinical, or IT in life sciences, this session is for you.